IMM 13.2% 29.5¢ immutep limited

Ann: Immutep to present Phase IIb breast cancer data at ESMO 2022, page-8

  1. 25,400 Posts.
    lightbulb Created with Sketch. 1377
    joe, read todays Ann in conjunction with recent
    fda related one mate….
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.